Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
1.050
-0.020 (-1.87%)
At close: Oct 9, 2025, 4:00 PM EDT
1.025
-0.025 (-2.38%)
Pre-market: Oct 10, 2025, 9:15 AM EDT
Applied Therapeutics Market Cap
Applied Therapeutics has a market cap or net worth of $151.21 million as of October 10, 2025. Its market cap has decreased by -83.76% in one year.
Market Cap
151.21M
Enterprise Value
123.39M
1-Year Change
-83.76%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since May 14, 2019, Applied Therapeutics's market cap has decreased from $160.29M to $151.21M, a decrease of -5.66%. That is a compound annual growth rate of -0.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 151.21M | 51.78% |
| Dec 31, 2024 | 99.62M | -61.49% |
| Dec 29, 2023 | 258.72M | 608.33% |
| Dec 30, 2022 | 36.52M | -84.43% |
| Dec 31, 2021 | 234.63M | -52.60% |
| Dec 31, 2020 | 494.96M | -2.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 764.25B |
| Johnson & Johnson | 460.23B |
| AbbVie | 408.07B |
| UnitedHealth Group | 338.63B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 232.23B |